Back to Trials
NCT06472804Recruiting

Insomnia in Patients With Metastatic Lung Cancer

Mayo Clinic

Start Date

6/19/2019

Completion Date

6/1/2027

Summary

This study evaluates how common insomnia (difficulties with sleep) is in patients with lung cancer that has spread from where it first started (primary site) to other places in the body.

Detailed Description

PRIMARY OBJECTIVE: I. Evaluate the frequency of insomnia in patients with metastatic non-small cell lung cancer. OUTLINE: This is an observational study. Patients undergo medical chart review and complete a questionnaire on study.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Have a diagnosis of metastatic non small cell lung cancer * Undergoing 1st, 2nd or 3rd line of treatment or are in maintenance therapy * Older than 18 years old at the time of diagnosis Exclusion Criteria: * Subjects will be excluded if they are considered to have advanced terminal cancer, severe depression or other psychiatric disorder or a sleep disorder other than insomnia (sleep apnea, restless leg syndrome, sleep related disorder of breathing), regular use of psychotropic medication other than hypnotics (eg antidepressants) per chart review

Interventions

OTHER

Non-Interventional Study

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Metastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

Locations

Mayo Clinic in Rochester

Rochester, Minnesota 55905

United States